Kronos Bio Stock Probability of Future Stock Price Finishing Over 4.20
| KRON Stock | USD 0.90 0.03 3.45% |
Kronos |
Kronos Bio Target Price Odds to finish over 4.20
The tendency of Kronos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 4.20 or more in 90 days |
| 0.90 | 90 days | 4.20 | close to zero percent |
Based on a normal probability distribution, the odds of Kronos Bio to move over $ 4.20 or more in 90 days from now is close to zero percent (This Kronos Bio probability density function shows the probability of Kronos Stock to fall within a particular range of prices over 90 days) . Probability of Kronos Bio price to stay between its current price of $ 0.90 and $ 4.20 at the end of the 90-day period is about 85.12 .
Given the investment horizon of 90 days Kronos Bio has a beta of 0.36. This indicates as returns on the market go up, Kronos Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Kronos Bio will be expected to be much smaller as well. Additionally Kronos Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Kronos Bio Price Density |
| Price |
Predictive Modules for Kronos Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kronos Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kronos Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Kronos Bio is not an exception. The market had few large corrections towards the Kronos Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kronos Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kronos Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | 0.36 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.08 |
Kronos Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kronos Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kronos Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kronos Bio generated a negative expected return over the last 90 days | |
| Kronos Bio has some characteristics of a very speculative penny stock | |
| Kronos Bio has high historical volatility and very poor performance | |
| Kronos Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.29 M. Net Loss for the year was (112.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kronos Bio currently holds about 267.89 M in cash with (78.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024 |
Kronos Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kronos Stock often depends not only on the future outlook of the current and potential Kronos Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kronos Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.7 M | |
| Cash And Short Term Investments | 173 M |
Kronos Bio Technical Analysis
Kronos Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Kronos Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kronos Bio. In general, you should focus on analyzing Kronos Stock price patterns and their correlations with different microeconomic environments and drivers.
Kronos Bio Predictive Forecast Models
Kronos Bio's time-series forecasting models is one of many Kronos Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kronos Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Kronos Bio
Checking the ongoing alerts about Kronos Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kronos Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Kronos Bio generated a negative expected return over the last 90 days | |
| Kronos Bio has some characteristics of a very speculative penny stock | |
| Kronos Bio has high historical volatility and very poor performance | |
| Kronos Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.29 M. Net Loss for the year was (112.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kronos Bio currently holds about 267.89 M in cash with (78.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024 |
Check out Kronos Bio Backtesting, Kronos Bio Valuation, Kronos Bio Correlation, Kronos Bio Hype Analysis, Kronos Bio Volatility, Kronos Bio History as well as Kronos Bio Performance. To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Bio. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.43) | Revenue Per Share 0.143 | Quarterly Revenue Growth 0.442 | Return On Assets (0.28) | Return On Equity (0.63) |
The market value of Kronos Bio is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Bio's value that differs from its market value or its book value, called intrinsic value, which is Kronos Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Bio's market value can be influenced by many factors that don't directly affect Kronos Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.